Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00527839 · ClinicalTrials.gov registry record

Hospital for Special Surgery Shoulder Arthroplasty Cohort

A clinical trial of Shoulder Arthroplasty, sponsored by Hospital for Special Surgery, New York.

Recruiting
Registry status
250
Enrollment target
2
Study locations

NCT00527839: Recruiting study of Shoulder Arthroplasty, sponsored by Hospital for Special Surgery, New York.

NCT00527839 is a study of Shoulder Arthroplasty that is actively recruiting participants, run by Hospital for Special Surgery, New York. The registered enrollment target is 250 participants, below the 1,056-participant average among 5 other Shoulder Arthroplasty trials with a reported enrollment target (76% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00527839, a study of Shoulder Arthroplasty, is actively recruiting participants, sponsored by Hospital for Special Surgery, New York.

RECRUITING
Registry status
250 participants
Enrollment target
2
Study locations

Study Summary

Total joint replacements are some of the most successful medical devices developed over the last fifty years. They enable millions of people to remain ambulatory and pain free, with minimal risk. In 2002, over 200,000 total hip replacements, 350,000 total knee replacements, and 25,000 total or partial shoulder replacements were performed in the United States (HCUP data). Future use will likely be even higher: it is estimated that by the year 2020, the population 65 and over in developed countries will increase by 71%. Existing studies do not provide adequate prospective data to evaluate long-term outcomes. HSS is a world leader in total joint replacement including total shoulder arthroplasty. However, there is no systematic follow-up or evaluation of patients who have their shoulders replaced here. The purpose of this study is to establish a prospective cohort of HSS total shoulder arthroplasty to evaluate predictors of outcome, causes of failure and to allow ongoing evaluation of the results of our patients over time.

Primary Outcome

Patient reported outcomes (PROMs) at 1 year, 2 year, 5 year, 10 year follow-up time points. This information will be collected and maintained for use in future research studies with their own individually defined outcomes.

Conditions Studied

Study Locations (2)

New York

  • Hospital for Special Surgery - New York
  • Hospital for Special Surgery - New York

Trial Details

FieldValue
Enrollment Target 250 participants
Start Date 2007-04
Est. Completion 2027-04

What NCT00527839 shows while recruiting

NCT00527839 is an observational study that tracks outcomes without assigning an intervention. The registered 250 participants enrollment target is mid-sized for trials with a published cap, below the 1,056-participant average among 5 other Shoulder Arthroplasty trials with a reported enrollment target (76% lower).

The record links to 1 condition, with Shoulder Arthroplasty appearing as the primary indexed condition, and to 0 interventions.

NCT00527839 reports a single indexed study location in New York.

Frequently Asked Questions

What is clinical trial NCT00527839 about?

NCT00527839 is a clinical study titled "Hospital for Special Surgery Shoulder Arthroplasty Cohort". Total joint replacements are some of the most successful medical devices developed over the last fifty years. They enable millions of people to remain ambulatory and pain free, with minimal risk. In 2002, over 200,000 total hip replacements, 350,000 total knee replacements, and 25,000 total or parti...

What is the current status of trial NCT00527839?

This trial is currently recruiting. The enrollment target is 250 participants. The study started on 2007-04. Estimated completion is 2027-04.

What conditions does trial NCT00527839 study?

This clinical trial studies the following conditions: Shoulder Arthroplasty.

Who is sponsoring clinical trial NCT00527839?

This trial is sponsored by Hospital for Special Surgery, New York, which has 194 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00527839 being conducted?

This trial has 2 study locations across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Shoulder Arthroplasty

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00483249 · 250 participants · NA

    Endovascular Exclusion of Thoracoabdominal and/or Paravisceral Abdominal Aortic Aneurysm

  • NCT00777712 · 250 participants

    Mechanisms Underlying Impaired Diabetic Wound Healing

  • NCT01451502 · 250 participants · NA

    Infusion of Cell Populations From Unlicensed Umbilical Cord Blood Units

  • NCT01771718 · 250 participants

    Pilot Study on In-vivo Non-invasive Skin Imaging Using Multiphoton Microscopy

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00527839, the US trial registry maintained by the National Library of Medicine. NCT00527839 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.